I can’t tell you how excited we are to announce that we’ve validated a breakthrough technology with our partner Cryoport that promises to significantly lower your shipping costs.  For those of you who aren’t familiar, Cryoport provides frozen shipping solutions for clinical labs, diagnostic companies, research organizations, biotech and pharmaceutical industries.

They’ve developed an innovative cold chain shipping solution that serves as an alternative to dry-ice packaging, therefore eliminating the costs associated with re-icing specimens during transit. Cryoport’s dry vapor shipper allows tissue samples, blood and other biological material to remain frozen at or below -150ºC for 10+ days!

We’ve been working with them for the past six months, assessing the movement and temperature profile on nearly 600 specimens, to confirm that its technology meets international regulatory compliance standards.

We are proud to announce that we’ve now moved into production mode and are offering this innovative cold chain shipping solution to our global customers.

Have you had experience with dry vapor shipping methods? Are you familiar with Cryoport? Leave a comment with your experiences.